EU-Authorized Hydrogen Peroxide Biocides from P&G: What Manufacturers and Distributors Must Do

Key data

If your company manufactures, distributes, or professionally uses hydrogen peroxide-based disinfectants and biocides, this regulation changes the rules of the game. The Commission Implementing Regulation (EU) 2026/2051, published on September 14, 2026, grants a Union authorization for the product family "Hydrogen peroxide product family_P&G" from Procter & Gamble, with direct validity in all Member States.

Until now, marketing biocides in different EU countries could require separate national authorizations. With this single authorization, P&G can distribute these products throughout Europe under a single regulatory framework, but in return all operators in the supply chain—not just P&G—must strictly comply with the technical, labeling, and safety conditions established by the regulation.

What does this regulation establish?

The regulation is based on the Regulation (EU) No. 528/2012 on the marketing and use of biocides, the European framework that regulates all biocidal products on the internal market.

The key points it establishes are:

• Union authorization: allows marketing the product family in all Member States without processing individual national authorizations.
• Active substance: hydrogen peroxide (hydrogen peroxide) as the active ingredient of all products in the family.
• Technical conditions and specifications: products must comply with specific requirements set out in the regulation text regarding formulation, concentration, and application.
• Labeling requirements: the labeling of each product must comply with the specifications established in the authorization.
• Use and safety requirements: professional users must respect the safe use conditions defined in the regulation.

This authorization is not a blank check: any operator distributing or using these biocides must verify that their activity complies with the specific approved conditions, not just general sector requirements.

Economic and operational impact

The single European authorization has direct operational consequences for the entire biocide value chain:

From a cost perspective, the main burden falls on labeling review and update and training of professional users on the new use conditions. Companies that already operated under previous national authorizations for equivalent products will need to assess whether their current procedures are compatible with the new regulation's specifications.

Who does it affect?

• Manufacturers of biocides and disinfectants based on hydrogen peroxide operating in the EU.
• Wholesale and retail distributors of biocidal products in any Member State.
• Professional cleaning and disinfection companies that use these products in their services.
• Hospitals, clinics, and healthcare facilities that use hydrogen peroxide biocides in disinfection protocols.
• Food and processing industry that uses hydrogen peroxide disinfectants in its facilities.
• Procurement and regulatory compliance managers in companies that purchase or manage these products.
• Importers and exporters of biocides within the European single market.

Practical example

A Spanish industrial cleaning services company uses hydrogen peroxide-based disinfectant products from P&G's range in its contracts with clients in the food sector.

With the entry into force of Regulation (EU) 2026/2051, this company must:

1. Verify that the specific products it uses belong to the "Hydrogen peroxide product family_P&G" family covered by the authorization.
2. Check that the labeling of the containers it receives from the distributor complies with the technical specifications approved in the regulation.
3. Review its safety data sheets and internal use protocols to ensure that doses, application methods, and protective measures comply with the authorized use conditions.
4. Update staff training on safe use conditions if the approved specifications differ from previous ones.

If the company also operates in Portugal or France, the advantage is that the same EU authorization is valid in both countries, without the need to verify additional national authorizations for these products.

What should companies do now?

1. Identify if you use or distribute products from the "Hydrogen peroxide product family_P&G" family: review your company's active biocide product catalog to determine if you fall within the scope of this authorization.
2. Review product labeling: verify that containers in circulation comply with the labeling specifications set out in Regulation (EU) 2026/2051. If there are deviations, coordinate with the supplier or manufacturer.
3. Update safety data sheets and use protocols: compare the approved use and safety conditions with current internal procedures. Update where necessary.
4. Train user personnel: ensure that employees who handle these biocides know the authorized use conditions, especially in high-risk professional environments (healthcare, food, industrial).
5. Document compliance: keep a record of the verification performed to demonstrate conformity in the event of a possible inspection by the competent authorities.
6. Consult the full text of the regulation: access the official version on EUR-Lex to review the specific technical conditions applicable to each product in the family.

Official source

Consult complete regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602051